United Kingdom scientists have published a report in the respected medical journal, The Lancet, indicating that those at-risk from heart disease or heart attack should receive the H1N1 flu vaccine when it becomes widely available in approximately one month.
The peer-reviewed study considered 39 prior research projects, concluding that as many as half of all flu-related deaths were the result of prior heart conditions. Among the data there were clear indications that use of a flu vaccine in at-risk patients significantly reduced the risk of heart attack as a result of a flu infection.
It is expected that around 2.5 million people in the UK will be offered a flu vaccine as they are considered at-risk. Including those with heart disease, and at risk of heart attack, asthma and diabetes sufferers will be targetted.
This page is archived, and is no longer publicly editable.
Articles presented on Wikinews reflect the specific time at which they were written and published, and do not attempt to encompass events or knowledge which occur or become known after their publication.
Please note that due to our archival policy, we will not alter or update the content of articles that are archived, but will only accept requests to make grammatical and formatting corrections.
Note that some listed sources or external links may no longer be available online due to age.
This page is archived, and is no longer publicly editable.
Articles presented on Wikinews reflect the specific time at which they were written and published, and do not attempt to encompass events or knowledge which occur or become known after their publication.
Please note that due to our archival policy, we will not alter or update the content of articles that are archived, but will only accept requests to make grammatical and formatting corrections.
Note that some listed sources or external links may no longer be available online due to age.
